Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand ...
BALTIMORE--(BUSINESS WIRE)--Kallisio, a company developing patient-specific precision-therapy solutions, announced that it has collaborated with Stanford Health Care to support the clinical ...
NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine ...
NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine ...
SOUTH SAN FRANCISCO, Calif., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation chimeric antigen receptor (CAR) ...
Background: Diabetic foot ulcer (DFU) reduce the quality of life for diabetes patients and creates a significant economic burden on global healthcare systems. Although there has been recent progress ...
The studies were a setback for the optimistic view that semaglutide and other drugs used in obesity and diabetes treatment could help prevent a number of brain diseases. By Gina Kolata Gina Kolata has ...
Hello, I have successfully coded a simple and complete implementation of the ViT paper(A. Dosovitskiy et al (2021)) with improvements from better baselines paper (L. Beyer et al (2022)). Contents: A ...
Este artigo analisa se um julgamento conduzido com o uso de dispositivos técnicos, com transmissão direta simultânea de vídeo e áudio, pode causar uma limitação ou até uma ameaça à realização do ...
PiNACLE - H2H will evaluate rondecabtagene autoleucel (ronde-cel) versus investigator’s choice of approved CD19 CAR T-cell therapies in patients with aggressive large B-cell lymphoma receiving ...